Back to news

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

Globe Newswire•12/08/2026•07:00 ET
0
Whiz Insights

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in